Sector: Health Care
IDEXX LABORATORIES INC · Meeting: May 12, 2026
Directors FOR
3
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Election of Three Class II Directors
Junius has served since 2014 and IDEXX's 3-year return of +16.6% trails the S&P 500 (^GSPC) by 43.8 percentage points, but the policy threshold for a low-positive TSR company requires a 50pp gap to trigger a vote against, so the gap does not meet the threshold and no TSR concern applies; he shows no overboarding, attendance, or qualification issues.
Kingsley has served since 2016 and the same 43.8pp gap vs. ^GSPC does not meet the 50pp threshold required for a low-positive TSR company; he holds 2 outside public board seats (Polaris, Mirion), which is within the policy limit of fewer than 4, and there are no other disqualifying concerns.
Vandebroek has served since 2013 and the 43.8pp underperformance gap vs. ^GSPC falls short of the 50pp threshold needed to trigger an against vote for a low-positive TSR company; she holds 2 outside public board seats, meets attendance requirements, and has strong technology and R&D qualifications relevant to IDEXX's business.
All three Class II nominees — Junius, Kingsley, and Vandebroek — pass the TSR screen because IDEXX's 3-year return of +16.6% places it in the low-positive TSR band, which requires a 50pp underperformance gap versus ^GSPC to trigger an against vote, and the actual gap is only 43.8pp. No overboarding, attendance, independence, or qualification concerns were identified for any nominee.
CEO
Jonathan J. Mazelsky
Total Comp
$14,580,122
Prior Support
94%%
CEO total compensation of approximately $14.6 million is within a reasonable range for a large-cap healthcare company CEO, and the pay mix is heavily weighted toward variable pay — base salary represents only 9% of target total direct compensation while performance-based and equity awards represent 91% — well exceeding the 50-60% variable pay threshold required by policy. Prior year say-on-pay support was 94%, far above the 70% threshold that would require a response, and the company's clawback policy is described as complying with and exceeding applicable Nasdaq and SEC requirements. While IDEXX's 3-year TSR of +16.6% trails the S&P 500 (^GSPC) by 43.8 percentage points, the policy requires above-benchmark variable pay combined with more than 20pp TSR underperformance to trigger a no vote on pay-for-performance grounds, and compensation levels do not appear to be clearly above benchmark given the strong pay-mix structure and the company's strong absolute operational and financial results in 2025.
Auditor
PricewaterhouseCoopers LLP
Tenure
23 yrs
Audit Fees
$2,767,207
Non-Audit Fees
$652,663
Non-audit fees (tax fees of $610,412 plus audit-related fees of $40,251 plus other fees of $2,000, totaling $652,663) represent approximately 23.6% of audit fees of $2,767,207, well below the 50% threshold that would raise independence concerns; PwC's tenure of approximately 23 years (since 2002) is below the 25-year threshold requiring a compelling rationale; and PwC is a Big 4 firm fully appropriate for IDEXX's ~$44.6 billion market cap.
3 proposals submitted by shareholders
Proposal 4
This is a board-initiated charter amendment that moves IDEXX away from a classified board structure — where directors serve staggered three-year terms — toward annual elections for all directors, phased in from 2027 to 2029. Annual director elections are a mainstream governance improvement that gives shareholders more regular accountability over the board, and the board is bringing this proposal specifically in response to significant shareholder support for declassification at the 2025 annual meeting. Supporting this proposal improves shareholder rights, even though the transition is phased rather than immediate.
Proposal 5
This board-initiated charter amendment creates a new right for shareholders who collectively own at least 25% of IDEXX's shares to require the company to call a special shareholder meeting — a right that does not currently exist. Giving shareholders the ability to call special meetings is a standard governance improvement that increases accountability between annual meetings, and the 25% ownership threshold is a reasonable market-standard level that prevents abuse by very small minority holders. This is a straightforward improvement in shareholder rights and warrants support.
Proposal 6
This shareholder proposal asks for a 10% ownership threshold to call a special meeting, while the board is simultaneously putting forward a binding charter amendment (Proposal 5) that would grant shareholders a 25% special meeting right. Because the board's own Proposal 5 substantially addresses the core ask — creating a new shareholder right to call special meetings — voting for this proposal is unnecessary and the 10% threshold it seeks could enable a small group of shareholders to trigger costly special meetings that may not reflect the broader shareholder base's interests. Supporting Proposal 5 while voting against this proposal is the appropriate outcome.
The 2026 IDEXX annual meeting ballot covers six proposals, with all three standard proposals (director elections, auditor ratification, and say-on-pay) receiving FOR determinations based on clean governance profiles, a well-structured pay program, and PwC fees well within independence thresholds. The two board-initiated charter amendments to declassify the board and create a 25% special meeting right are both supported as meaningful governance improvements, while the shareholder proposal for a 10% special meeting right is voted against because Proposal 5 already substantially addresses the underlying concern.
1 companies disclosed in 2026 proxy filing